MedPath

Psychometric Validation of the Competitive Attention Test

Not Applicable
Terminated
Conditions
Attention Deficit Hyperactivity Disorder
Registration Number
NCT03942835
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

This project aims at validating a new neuropsychological test to measure voluntary and involuntary attention for clinical use to diagnose attentional deficits.

This project proposes:

* a test-retest procedure in healthy subjects aged from 6 to 90 year-old;

* testing in attention deficit hyperactivity disorder (ADHD) patients before psychostimulant treatment;

* testing in attention deficit hyperactivity disorder (ADHD) patients before psychostimulant treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
26
Inclusion Criteria

healthy major participants:

  • Age from 18 to 90 year-old
  • Informed consent to participate in the study
  • No neurological or psychiatric disorder
  • No history of neuro-psychiatric disorder or neurodevelopmental type dysphasia, dyslexia, dyspraxia, attention deficit disorder

healthy minor participants:

  • Age from 6 to 17 year-old
  • Informed consent of parents or guardians for the child's participation in the study
  • No neurological or psychiatric disorder
  • No history of neuro-psychiatric disorder or neurodevelopmental type dysphasia, dyslexia, dyspraxia, Attention deficit disorder

ADHD minor patients:

  • Age from 6 to 17 year-old
  • Informed consent of parents or guardians for the child's participation in the study
  • ADHD Diagnosis with or without hyperactivity
  • No psychiatric history other than ADHD.
  • For Experience 3: treatment in progress.
Read More
Exclusion Criteria

healthy major participants

  • Age below 18 or above 90 year-old
  • unaffiliated or non-beneficiaries of the social security scheme

healthy minor participants:

  • Age below 6 or above 18 year-old
  • unaffiliated or non-beneficiaries of the social security scheme

ADHD minor patients:

  • Age below 6 or above 18 year-old
  • unaffiliated or non-beneficiaries of the social security scheme
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reaction times in healthy subjects and patients with ADHD.6 weeks

Reaction times in milliseconds obtained with the CAT test in healthy participants and in patients with ADHD.

Secondary Outcome Measures
NameTimeMethod
Percentage of correct responses in healthy subjects and patients with ADHD.6 weeks

Percentage of correct responses obtained with the CAT test in healthy participants and in patients with ADHD.

Trial Locations

Locations (1)

Centre de Recherche en Neurosciences de Lyon, INSERM U1028

🇫🇷

Bron, France

© Copyright 2025. All Rights Reserved by MedPath